DWJ1252

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

BioequivalenceFunctional Dyspepsia

Phase 1

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

CompletedNCT01094847

Daewoong Pharmaceutical Co. LTD.Bioequivalence

Start: 2010-04-30Target: 30Updated: 2011-05-20

Phase 3

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

CompletedNCT03024086

Daewoong Pharmaceutical Co. LTD.Functional Dyspepsia

Start: 2016-12-12End: 2017-04-25Target: 124Updated: 2019-06-26

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

CompletedNCT03184402

Daewoong Pharmaceutical Co. LTD.Functional Dyspepsia

Start: 2017-04-24End: 2017-07-31Updated: 2019-06-26